Bulletin
Investor Alert

INmune Bio Inc.

NAS: INMB

GO
/marketstate/country/us

After Hours

/zigman2/quotes/206182062/composite

$

9.16

Change

-0.12 -1.29%

Volume

Volume 56

Jul 5, 2022, 7:57 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/206182062/composite

Previous close

$ 8.77

$ 9.28

Change

+0.51 +5.82%

Day low

Day high

$8.68

$9.44

Open
Open: 8.68

52 week low

52 week high

$4.63

$30.37

Open

Market cap

$157.39M

Average volume

141,429

P/E ratio

N/A

Rev. per Employee

$34,000

EPS

-1.92

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/inmb

MarketWatch News on INMB

  1. INmune Bio downgraded to neutral from buy at B. Riley

    7:51 a.m. May 24, 2022

    - Tomi Kilgore

  2. INmune Bio stock price target cut to $7 from $14 at B. Riley

    7:52 a.m. May 24, 2022

    - Tomi Kilgore

  3. Robinhood investors are propping up this stock market, says JPMorgan

    9:33 a.m. Sept. 2, 2021

    - Barbara Kollmeyer

  4. Analyst Raises Price Targets on 3 Smaller Alzheimer's Stocks

    11:50 a.m. July 7, 2021

    - Barron's Online

  5. INmune Bio stock price target raised to $42 from $32 at Maxim Group

    8:31 a.m. July 7, 2021

    - Tomi Kilgore

  6. INmune Bio started at buy with $29 stock price target at B. Riley

    7:23 a.m. April 21, 2021

    - Tomi Kilgore

  7. INmune Bio stock price target raised to $32 from $16 at Maxim Group

    8:39 a.m. Jan. 22, 2021

    - Tomi Kilgore

  8. INmune Bios started at buy with $13 stock price target at Maxim Group

    7:38 a.m. March 19, 2019

    - Tomi Kilgore

/news/nonmarketwatch/company/us/inmb

Other News on INMB

  1. Alzheimer’s drug developers are on decline after Roche setback

    11:44 a.m. June 16, 2022

    - Seeking Alpha

  2. INmune Bio: Possibly The Once In A Lifetime Dip

    11:28 a.m. May 25, 2022

    - Seeking Alpha

  3. PLG, ZTEK and BBAI among mid-day movers

    1:06 p.m. May 24, 2022

    - Seeking Alpha

  4. INmune Bio, Inc. (INMB) Q1 2022 Earnings Call Transcript

    1:30 p.m. May 6, 2022

    - Motley Fool

  5. Notable earnings after Thursday's close

    5:35 p.m. May 4, 2022

    - Seeking Alpha

  6. Hypotheses Underlying Alzheimer's Drug Development

    1:06 p.m. April 26, 2022

    - Seeking Alpha

  7. KNDI, LILM and ADN among mid- day movers

    12:38 p.m. March 24, 2022

    - Seeking Alpha

  8. Loading more headlines...
/news/pressrelease/company/us/inmb

Press Releases on INMB

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.